Studies outlined the role of the mammalian target of rapamycin (mTOR) in the pathogenesis of renal and hepatic cyst formation and growing, and experimental studies suggest mTOR inhibitors efficacy as treatment in ADPKD. This evidence concerns the gene MTOR and Hepatic cysts.